Atoz Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 24.33%
- Profit Growth 22.49%
- Ebitda 24.32%
- Net Worth 11.15%
- Total Assets 20.04%
About Atoz Pharmaceuticals
Atoz Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 12 February 1998 and has a history of 26 years and 11 months. Its registered office is in Tiruvallur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Viswanathan Shanmugasundaram and Rajakantham Rajiniganth serve as directors at the Company.
Company Details
-
Location
Tiruvallur, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TN1998PTC039891
-
Company No.
039891
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Feb 1998
-
Date of AGM
22 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Atoz Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viswanathan Shanmugasundaram
|
Director | 09-Oct-2015 | Current |
|
Rajakantham Rajiniganth
|
Director | 03-Oct-2022 | Current |
Financial Performance of Atoz Pharmaceuticals.
Atoz Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.33% increase. The company also saw a substantial improvement in profitability, with a 22.49% increase in profit. The company's net worth Soared by an impressive increase of 11.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atoz Pharmaceuticals?
In 2023, Atoz Pharmaceuticals had a public holding of 60.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Flaring Formulations Private LimitedViswanathan Shanmugasundaram is a mutual person
-
Azidus Laboratories LimitedViswanathan Shanmugasundaram is a mutual person
-
Baddi Print Packs Private LimitedViswanathan Shanmugasundaram and Rajakantham Rajiniganth are mutual person
-
Kinesis Laboratories Private Limited
Viswanathan Shanmugasundaram is a mutual person
-
Kinesis Pharmaceuticals Private Limited
Viswanathan Shanmugasundaram is a mutual person
-
Innocia Lifesciences Private Limited
Viswanathan Shanmugasundaram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Atoz Pharmaceuticals?
Atoz Pharmaceuticals has a workforce of 60 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atoz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atoz Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
